233 related articles for article (PubMed ID: 12423450)
21. The use of albumin in patients with decompensated cirrhosis: the case in favor.
Maor Y
Isr Med Assoc J; 2005 Feb; 7(2):115-8. PubMed ID: 15729966
[TBL] [Abstract][Full Text] [Related]
22. [Renal impairment in liver diseases].
Gerbes AL; Gülberg V
Praxis (Bern 1994); 2006 Oct; 95(40):1535-8. PubMed ID: 17048410
[TBL] [Abstract][Full Text] [Related]
23. Review article: Management of ascites and associated complications in patients with cirrhosis.
Kuiper JJ; de Man RA; van Buuren HR
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
[TBL] [Abstract][Full Text] [Related]
24. AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.
Caraceni P; Angeli P; Prati D; Bernardi M; ; Liumbruno GM; Bennardello F; Piccoli P; Velati C;
Blood Transfus; 2016 Jan; 14(1):8-22. PubMed ID: 26820615
[TBL] [Abstract][Full Text] [Related]
25. Large-volume paracentesis and volume re-expansion: can synthetic plasma expanders safely replace albumin?
Salerno F
J Hepatol; 1992 Mar; 14(2-3):143-5. PubMed ID: 1500676
[No Abstract] [Full Text] [Related]
26. Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study.
Hamdy H; ElBaz AA; Hassan A; Hassanin O
J Clin Gastroenterol; 2014 Feb; 48(2):184-8. PubMed ID: 23842215
[TBL] [Abstract][Full Text] [Related]
27. AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis.
;
Dig Liver Dis; 2016 Jan; 48(1):4-15. PubMed ID: 26802734
[TBL] [Abstract][Full Text] [Related]
28. Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study.
Singh V; Kumar B; Nain CK; Singh B; Sharma N; Bhalla A; Sharma AK
J Intern Med; 2006 Jul; 260(1):62-8. PubMed ID: 16789980
[TBL] [Abstract][Full Text] [Related]
29. Renal and circulatory effects of large volume plasma expansion in patients with hepatorenal syndrome type 1.
Umgelter A; Wagner KS; Reindl W; Luppa PB; Geisler F; Huber W; Schmid RM
Ann Hepatol; 2012; 11(2):232-9. PubMed ID: 22345341
[TBL] [Abstract][Full Text] [Related]
30. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
Gentilini P; Laffi G; La Villa G; Raggi VC
Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
[TBL] [Abstract][Full Text] [Related]
31. Treatment of ascites and renal failure in cirrhosis.
Ginès P; Arroyo V; Rodés J
Baillieres Clin Gastroenterol; 1989 Jan; 3(1):165-86. PubMed ID: 2655748
[TBL] [Abstract][Full Text] [Related]
32. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.
Durand F; Graupera I; Ginès P; Olson JC; Nadim MK
Am J Kidney Dis; 2016 Feb; 67(2):318-28. PubMed ID: 26500178
[TBL] [Abstract][Full Text] [Related]
34. Hepatorenal syndrome.
Ginès P; Solà E; Angeli P; Wong F; Nadim MK; Kamath PS
Nat Rev Dis Primers; 2018 Sep; 4(1):23. PubMed ID: 30213943
[TBL] [Abstract][Full Text] [Related]
35. [Physiopathology of refractory ascites and the hepatorenal syndrome].
Arroyo V
Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
[No Abstract] [Full Text] [Related]
36. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
Fagundes C; Ginès P
Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
[TBL] [Abstract][Full Text] [Related]
37. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
[TBL] [Abstract][Full Text] [Related]
38. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis.
Saló J; Ginès A; Ginès P; Piera C; Jiménez W; Guevara M; Fernández-Esparrach G; Sort P; Bataller R; Arroyo V; Rodés J
J Hepatol; 1997 Oct; 27(4):645-53. PubMed ID: 9365040
[TBL] [Abstract][Full Text] [Related]
39. [Ascites, hepatorenal syndrome and spontaneous bacterial peritonitis in patients with portal hypertension].
Kim YS
Korean J Gastroenterol; 2010 Sep; 56(3):168-85. PubMed ID: 20847607
[TBL] [Abstract][Full Text] [Related]
40. Hepatorenal syndrome.
Guevara M; Rodés J
Int J Biochem Cell Biol; 2005 Jan; 37(1):22-6. PubMed ID: 15381144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
